Premium
Ahmedabad-based bulk drug maker Concord Biotech Ltd is in talks with strategic players for a partnership to enter into the biosimilars market, a top executive of the company told VCCircle.“Due to manufacturing complexity, technical competency is the key to enter into biosimilars market. We are in talks with a few ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
